WASHINGTON, May 13, 2026 /PRNewswire/ -- A new awareness campaign, This is ALZ, launched today to challenge long-held perceptions of Alzheimer's by revealing what the disease looks like in its earlier ...
FRAMINGHAM, Mass., April 07, 2026--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for ...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of product candidates and diagnostic assays for patients suffering from ...
Add Yahoo as a preferred source to see more of our stories on Google. June is Alzheimer’s & Brain Awareness Month, and the Alzheimer’s Association is encouraging individuals and families across the ...
Early, Sustained and Statistically Significant Reduction in Plasma P-tau 181 Reaching 31% at 24 Months Supports Disease Modification in Carriers of One or Two Copies of APOE4 Gene who Represent Two ...
(WFSB) - June is Connecticut Alzheimer’s and Brain Awareness Month, part of a nationwide effort to spotlight a disease that impacts millions of families. As part of the campaign, the Alzheimer’s ...
ALZ-NET is the first network developed specifically for new FDA-approved Alzheimer's treatments, collecting real-world evidence on drug effectiveness and side effects over a long period of time. The ...
Please provide your email address to receive an email when new articles are posted on . The Alzheimer’s Association is among a group of professional societies and research institutions that have ...
MedPage Today on MSN
Study questions methods used in Alzheimer's drug analysis
Quantile aggregation may lead to overstated claims about amyloid-cognition relationships ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results